Captura Biopharma

Dedicated to rapid & effective treatment of Nuclear/Radiation Exposure & Heavy Metal Poisonings.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Little Rock, AR, USA
  • Currency USD
  • Founded May 2019
  • Employees 4
  • Incorporation Type C-corp
  • Website Www.capturabiopharma.com

Company Summary

Captura is a biopharmaceutical company dedicated to averting a public health crisis related to nuclear radiation, lead and other toxic heavy metal poisonings. We have a a novel, oral agent C2E2, that can avert the crisis.
C2E2 falls under the FDA’s “Animal Rule”: no need for costly & lengthy Phase 2 and Phase 3 trials. $14M from NIH enabled us to de-risk the technical, safety, and toxicity end-points typical of other drug development programs.

Team

  • Chief Medical Officer

    He has been practicing Emergency Medicine for over 30 years & is board certified. Graduate of Fordham University with a B.S. in Biology & received a M.D. from Georgetown University. Trained in Emergency Medicine & Cardiac Research at Henry Ford Hospital. Chairman of the INOVA Health System IRB for 14 years & versed in human clinical research trials. Training includes knowledge in biohazards, radiation sickness, disaster medicine & toxicology.

  • Michael Geranen
    CEO

    Experienced CEO with a demonstrated history in the pharmaceutical industry. Skilled in Finance and Product Development in the Branded and Generic pharmaceutical industry. Experienced working with the U.S. Food and Drug Administration (FDA), Strategic Planning and financial structuring to support development investment to-cash flow positive outcomes.

  • Anthony Soscia
    President & Co-Founder

    Senior pharmaceutical leader with over 25 years of experience growing companies and portfolios in both the branded generic & generic space. He has substantial experience in API manufacturing, developing innovative therapies, hard to formulate product, active pharmaceutical ingredient, & finished dosage development. He also has an extensive international network of finished dosage and active ingredient contacts and business development expertise.

Advisors

  • Michael Jay, PhD
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free